RxDoctor Payments Data

Lucia Hamilton

Nurse Practitioner · Kissimmee, FLNPI 1275134819

Payments from drug & device makers

$1,675in general payments, 2019–2025

Across 97 payments — averaging $17.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$480
  • Sunovion Pharmaceuticals Inc.$222
  • Lundbeck LLC$162
  • Otsuka America Pharmaceutical, Inc.$129
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$75
  • AstraZeneca$72
  • plus $534 from 15 others

What the payments were for

  • Food & beverage$1,66199%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,675 in reported general payments places this provider in the 80th percentile of 8,290 nurse practitioner providers in Florida.

See all nurse practitioner providers in Florida

Medicare billing

Part B allowed, 2024
$4,782
Medicare patients
44
Services billed
68

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol21$17,719
MyrbetriqMirabegron12$13,905
OzempicSemaglutide12$10,577
VascepaIcosapent Ethyl14$8,995
Rosuvastatin Calcium243$2,322
SynthroidLevothyroxine Sodium13$1,164
Fenofibrate35$929
Lisinopril126$838
Albuterol Sulfate HfaAlbuterol Sulfate23$762
Levothyroxine Sodium83$736
Ezetimibe44$726
Gabapentin46$623
Losartan Potassium106$606
Atorvastatin Calcium94$582
Trazodone Hcl28$568

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$72$17,71921 claims
Novo NordiskOzempic$43$10,57712 claims
AbbVieSynthroid$480$1,16413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,290 nurse practitioner providers in Florida.

Other nurse practitioner in Kissimmee

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →